137 related articles for article (PubMed ID: 31673266)
1. Molecular Characterization of Aquaglyceroporine: A Novel Mutation in
Eslami G; Ghavami M; Moradi AR; Nadri H; Ahmadian S
Iran J Parasitol; 2019; 14(3):465-471. PubMed ID: 31673266
[TBL] [Abstract][Full Text] [Related]
2. Alteration in glycerol and metalloid permeability by a single mutation in the extracellular C-loop of Leishmania major aquaglyceroporin LmAQP1.
Uzcategui NL; Zhou Y; Figarella K; Ye J; Mukhopadhyay R; Bhattacharjee H
Mol Microbiol; 2008 Dec; 70(6):1477-86. PubMed ID: 19019150
[TBL] [Abstract][Full Text] [Related]
3. The role of alanine 163 in solute permeability of Leishmania major aquaglyceroporin LmAQP1.
Mukhopadhyay R; Mandal G; Atluri VS; Figarella K; Uzcategui NL; Zhou Y; Beitz E; Ajees AA; Bhattacharjee H
Mol Biochem Parasitol; 2011 Jan; 175(1):83-90. PubMed ID: 20888371
[TBL] [Abstract][Full Text] [Related]
4. Biochemical characterization of Leishmania major aquaglyceroporin LmAQP1: possible role in volume regulation and osmotaxis.
Figarella K; Uzcategui NL; Zhou Y; LeFurgey A; Ouellette M; Bhattacharjee H; Mukhopadhyay R
Mol Microbiol; 2007 Aug; 65(4):1006-17. PubMed ID: 17640270
[TBL] [Abstract][Full Text] [Related]
5. Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin.
Gourbal B; Sonuc N; Bhattacharjee H; Legare D; Sundar S; Ouellette M; Rosen BP; Mukhopadhyay R
J Biol Chem; 2004 Jul; 279(30):31010-7. PubMed ID: 15138256
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo anti-parasitic activity of biogenic antimony sulfide nanoparticles on Leishmania major (MRHO/IR/75/ER).
Mohtasebi S; Mohebali M; Elikaee S; Akhoundi B; Foroushani AR; Teimouri A; Yarizadeh H
Parasitol Res; 2019 Sep; 118(9):2669-2678. PubMed ID: 31278518
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER).
Soleimanifard S; Arjmand R; Saberi S; Khamesipour A; Kazemi M; Salehi M; Akbari M; Hejazi S
Iran J Parasitol; 2014 Sep; 9(3):423-8. PubMed ID: 25678928
[TBL] [Abstract][Full Text] [Related]
8. Molecular Modeling and Structural Stability of Wild-Type and Mutant CYP51 from Leishmania major: In Vitro and In Silico Analysis of a Laboratory Strain.
Keighobadi M; Emami S; Lagzian M; Fakhar M; Rafiei A; Valadan R
Molecules; 2018 Mar; 23(3):. PubMed ID: 29562710
[TBL] [Abstract][Full Text] [Related]
9. Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1.
Mandal G; Mandal S; Sharma M; Charret KS; Papadopoulou B; Bhattacharjee H; Mukhopadhyay R
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003500. PubMed ID: 25714343
[TBL] [Abstract][Full Text] [Related]
10. Comparison of p27 Gene Expression of Promastigote and Amastigote Forms of
Elikaee S; Mohebali M; Eslami H; Rezaei S; Najafian HR; Kazemi-Rad E; Keshavarz H; Eshraghian MR; Hajjaran H; Oshaghi MA; Ayazian Mavi S
Iran J Parasitol; 2018; 13(2):186-192. PubMed ID: 30069202
[TBL] [Abstract][Full Text] [Related]
11. Glucantime resistant Leishmania promastigotes are sensitive to pentostam.
Moreira ES; Guerra JB; Petrillo-Peixoto Mde L
Rev Soc Bras Med Trop; 1992; 25(4):247-50. PubMed ID: 1340539
[TBL] [Abstract][Full Text] [Related]
12. Comparison of
Özbilgin A; Çavuş İ; Kaya T; Yıldırım A; Harman M
Turkiye Parazitol Derg; 2020 Mar; 44(1):12-16. PubMed ID: 32212583
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application].
Henao HH; Osorio Y; Saravia NG; Gómez A; Travi B
Biomedica; 2004 Dec; 24(4):393-402. PubMed ID: 15678803
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of Leishmania viannia panamensis to pentavalent antimony is correlated with the formation of cleavable DNA-protein complexes.
Lucumi A; Robledo S; Gama V; Saravia NG
Antimicrob Agents Chemother; 1998 Aug; 42(8):1990-5. PubMed ID: 9687395
[TBL] [Abstract][Full Text] [Related]
15. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
Ephros M; Bitnun A; Shaked P; Waldman E; Zilberstein D
Antimicrob Agents Chemother; 1999 Feb; 43(2):278-82. PubMed ID: 9925518
[TBL] [Abstract][Full Text] [Related]
16. Gene expression of RNAP II, JBP1 and JBP2 in Leishmania major exposed to antimonials, amphotericin B and paromomycin.
Ajamein V; Eslami G; Ahmadian S; Khamesipour A; Elloumi M
Ann Parasitol; 2018; 64(3):181-187. PubMed ID: 30316208
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of an antimicrobial peptide against amastigote forms of
Khalili S; Mohebali M; Ebrahimzadeh E; Shayan E; Mohammadi-Yeganeh S; Moosazadeh Moghaddam M; Elikaee S; Akhoundi B; Sharifi-Yazdi MK
Vet Res Forum; 2018; 9(4):323-328. PubMed ID: 30713610
[TBL] [Abstract][Full Text] [Related]
18. Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action.
Sereno D; Cavaleyra M; Zemzoumi K; Maquaire S; Ouaissi A; Lemesre JL
Antimicrob Agents Chemother; 1998 Dec; 42(12):3097-102. PubMed ID: 9835497
[TBL] [Abstract][Full Text] [Related]
19. Potent antileishmanial activity of chitosan against Iranian strain of
Esboei BR; Mohebali M; Mousavi P; Fakhar M; Akhoundi B
J Vector Borne Dis; 2018; 55(2):111-115. PubMed ID: 30280708
[TBL] [Abstract][Full Text] [Related]
20. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes.
Ephros M; Waldman E; Zilberstein D
Antimicrob Agents Chemother; 1997 May; 41(5):1064-8. PubMed ID: 9145870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
